Sanofi Cash on Hand 2012-2026 | SNY | MacroTrends

Sanofi Cash on Hand 2012-2026 | SNY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sanofi cash on hand for the quarter ending March 31, 2026 was $6.489B, a 22.92% decline year-over-year.

Sanofi cash on hand for 2024 was $8.052B, a 14.59% decline from 2023.
Sanofi cash on hand for 2023 was $9.427B, a 29.75% decline from 2022.
Sanofi cash on hand for 2022 was $13.419B, a 12.32% increase from 2021.

Sanofi Cash on Hand 2012-2026 | SNY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sanofi cash on hand for 2024 was $8.052B, a 14.59% decline from 2023.
Sanofi cash on hand for 2023 was $9.427B, a 29.75% decline from 2022.
Sanofi cash on hand for 2022 was $13.419B, a 12.32% increase from 2021.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$887.6B
Johnson & Johnson (JNJ)	$574.4B
AbbVie (ABBV)	$367.7B
Roche Holding AG (RHHBY)	$318.8B
Merck (MRK)	$299.9B
Novartis AG (NVS)	$294B
Novo Nordisk (NVO)	$167.5B
Pfizer (PFE)	$153.1B
Bayer (BAYRY)	$46.2B
Innoviva (INVA)	$1.8B